BCM
CELUW icon

BlueCrest Capital Management’s Celularity Inc CELUW Stock Holding History

BlueCrest Capital Management’s Portfolio CELUW Stock Details CELUW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-78,706
Closed -$126K – 366
2020
Q3 		$126K Sell
78,706
-171,294
-69% -$258K ﹤0.01% 281
2020
Q2 		$275K Hold
250,000
– – 0.01% 207
2020
Q1 		$138K Hold
250,000
– – 0.01% 179
2019
Q4 		$200K Hold
250,000
– – 0.01% 345
2019
Q3 		$150K Buy
+250,000
New +$143K 0.01% 514

Other funds holding CELUW

LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
NFAM
North Fourth Asset Management Englewood Cliffs, New Jersey $164M AUM 43.6% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

BlueCrest Capital Management's CELUW Position: Q4 2020 in Review

BlueCrest Capital Management sold out of Celularity Inc (CELUW) in Q4 2020, closing a stake of 78,706 shares — an estimated $126K sold.

BlueCrest Capital Management first reported a position in CELUW in Q3 2019 and held it in 5 quarters. The position peaked at $275K in Q2 2020. 31 funds tracked by Wall St. Rank hold CELUW as of Q4 2020.

  • BlueCrest Capital Management reported no remaining Celularity Inc position as of Q4 2020 after selling out during the quarter.
  • BlueCrest Capital Management sold 78,706 Celularity Inc shares in Q4 2020, an estimated $126K.
  • BlueCrest Capital Management first reported a position in Celularity Inc in Q3 2019 and held it in 5 quarters.
  • BlueCrest Capital Management's Celularity Inc position peaked at $275K in Q2 2020.
  • 31 funds tracked by Wall St. Rank held Celularity Inc as of Q4 2020.

Based on BlueCrest Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.